Changes in Health-Related Quality of Life of Patients Treated for Esophageal Cancer in Eldoret, Kenya
DOI:
https://doi.org/10.47604/jhmn.2716Keywords:
Esophageal Cancer, Health-Related Quality of Life, FACT-E, DysphagiaAbstract
Purpose: The study objectives were: to determine the demographic and clinical characteristics of patients treated for EC in Eldoret and to determine the change in health-related quality of life of patients treated for EC.
Methodology: A longitudinal study was conducted at three cancer centers in Eldoret, Kenya. Participants were interviewed at enrollment (pre-treatment) and three months post-treatment. The study included patients aged 18 and above with histologically confirmed esophageal cancer. Consecutive sampling method was used to enroll study participants until a predetermined sample size of 59 was achieved. Independent variables considered were patient characteristics (demographic and clinical), and baseline HRQoL while the dependent variable was 3 months post-treatment HRQoL. Patients' characteristic data was analyzed using descriptive statistics (frequencies and percentages); change in HRQoL was calculated using the analysis of variance (ANOVA) test and the results were presented using tables.
Findings: At baseline, 59 patients (68% female, mean age 56.3 years) were enrolled. The most common complaints were dysphagia (100%) and weight loss (74.6%). The baseline mean HRQoL score was 107.1, indicating a compromised quality of life at the start of treatment. After treatment, patients receiving chemotherapy plus surgery showed improved HRQoL, while radiotherapy alone was associated with deterioration. The differences were statistically significant (p-values: 0.04 and 0.0092, respectively). Multivariate regression revealed that only baseline HRQoL was significantly associated with post-treatment HRQoL (p=0.0065).This study sheds light on the underexplored aspect of HRQoL in Kenyan esophageal cancer patients. The findings emphasize the impact of treatment modalities on HRQoL, with chemotherapy plus surgery showing better outcomes. The study underscores the importance of considering patients' baseline HRQoL in assessing post-treatment outcomes. Addressing these factors can inform targeted interventions to improve the overall well-being of esophageal cancer patients in Kenya. Further research with larger, more diverse samples is warranted to enhance the generalizability of these findings.
Unique Contribution to Theory Practice and Policy: This study highly recommends community sensitization and awareness of esophageal cancer to the at-risk population groups, further research on HRQoL as a prognostic marker for patients with esophageal cancer and more high-quality studies on HRQoL with large sample sizes are needed to determine the association between characteristics of the patients and health-related quality of life.
Downloads
References
Boorn, H. G. Van Den, Stroes, C. I., Zwinderman, A. H., Eshuis, W. J., & Laarhoven, H. W. M. Van. (2020). Critical Reviews in Oncology / Hematology Health-related quality of life in curatively-treated patients with esophageal or gastric cancer : A systematic review and meta-analysis. Critical Reviews in Oncology / Hematology, 154(August), 103069. https://doi.org/10.1016/j.critrevonc.2020.103069
Chesumbai, G. (2024). CANCER INCIDENCE IN UASIN GISHU COUNTY. February. https://doi.org/10.13140/RG.2.2.19551.84643
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021). Cancer statistics for the year 2020: An overview. International Journal of Cancer, 149(4), 778–789. https://doi.org/10.1002/ijc.33588
Herszényi, L., & Tulassay, Z. (2010). Epidemiology of gastrointestinal and liver tumors. European Review for Medical and Pharmacological Sciences, 14(4), 249–258.
Huang, F. L., & Yu, S. J. (2018). Esophageal cancer: Risk factors, genetic association, and treatment. Asian Journal of Surgery, 41(3), 210–215. https://doi.org/10.1016/j.asjsur.2016.10.005
Kidane, B, Coughlin, S., Vogt, K., & Malthaner, R. (2015). Preoperative chemotherapy for resectable thoracic esophageal cancer ( Review ). 5. https://doi.org/10.1002/14651858.CD001556.pub3.www.cochranelibrary.com
Kidane, Biniam, Ali, A., Sulman, J., Wong, R., Knox, J. J., & Darling, G. E. (2018a). Health-related quality of life measure distinguishes between low and high clinical T stages in esophageal cancer. Annals of Translational Medicine, 6(13), 270–270. https://doi.org/10.21037/atm.2018.06.03
Kidane, Biniam, Ali, A., Sulman, J., Wong, R., Knox, J. J., & Darling, G. E. (2018b). Health-related quality of life measure distinguishes between low and high clinical T stages in esophageal cancer. Annals of Translational Medicine, 6(13), 270–270. https://doi.org/10.21037/atm.2018.06.03
Liu, S., Hu, Z., Lin, Z., Lin, J., Bd, H. C., Rao, W., & Yu, K. (2020). Health ‐ related quality of life and treatment modality among esophageal squamous cell carcinoma survivors : A prospective study using time to deterioration model analysis. September, 1–8. https://doi.org/10.1002/jso.26264
Oh, D., Noh, J. M., Nam, H., Lee, H., Kim, T. G., & Ahn, Y. C. (n.d.). High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma. 1–6.
Parker, R. K., Dawsey, S. M., Abnet, C. C., & White, R. E. (2010). Frequent occurrence of esophageal cancer in young people in western Kenya. Diseases of the Esophagus, 23(2), 128–135. https://doi.org/10.1111/j.1442-2050.2009.00977.x
Rees, J., Hurt, C. N., Gollins, S., Mukherjee, S., Maughan, T., Falk, S. J., Staffurth, J., Ray, R., Bashir, N., I Geh, J., Cunningham, D., Roy, R., Bridgewater, J., Griffiths, G., SNixon, L., Blazeby, J. M., & Crosby, T. (2015). Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. British Journal of Cancer, 113(4), 603–610. https://doi.org/10.1038/bjc.2015.258
Sunde, B., Klevebro, F., Johar, A., Johnsen, G., Jacobsen, A. B., Glenjen, N. I., Friesland, S., Lindblad, M., Ajengui, A., Lundell, L., Lagergren, P., & Nilsson, M. (2019). Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial). British Journal of Surgery, 106(11), 1452–1463. https://doi.org/10.1002/bjs.11246
van den Boorn, H. G., Stroes, C. I., Zwinderman, A. H., Eshuis, W. J., Hulshof, M. C. C. M., van Etten-Jamaludin, F. S., Sprangers, M. A. G., & van Laarhoven, H. W. M. (2020). Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 154(August), 103069. https://doi.org/10.1016/j.critrevonc.2020.103069
WHO. (2019). Kenya Source: Globocan 2018. 985, 2.
Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., Zhang, L., Tang, J., Chen, J., Wei, K., Huang, S., Wang, J., Yu, L., Zhao, D., Song, G., Chen, J., Shen, Y., Yang, X., Gu, X., … Yu, X. Q. (2015). Cancer survival in China, 2003-2005: A population-based study. International Journal of Cancer, 136(8), 1921–1930. https://doi.org/10.1002/ijc.29227
Zhou, Y. C., Chen, L. L., Xu, H. B., Sun, Q., Zhang, Q., Cai, H. F., & Jiang, H. (2018). Aging-related prognosis analysis of definitive radiotherapy for very elderly esophageal cancer. Cancer Medicine, 7(5), 1837–1844. https://doi.org/10.1002/cam4.1456
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Tabitha Kamau, Diana Menya, Naftali Busakhala, Eva Ombiro, Elias Melly
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
